Douglas Warner
Förmögenhet: - $ per 2026-07-31
Förmögenhet: - $ per 2026-07-31
Douglas Warner is currently Chief Medical Officer at Tyra Biosciences, Inc. since 2024.
Formerly, Dr. Warner was Chief Medical Officer at eFFECTOR Therapeutics, Inc. from 2022 to 2024 and Executive Medical Director at Amgen, Inc. Education includes an undergraduate degree from the University of Pennsylvania, an MBA from UCLA Anderson School of Management, and a doctorate from Duke University School of Medicine.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
TYRA BIOSCIENCE, INC -.--% | 2026-05-05 | 0 ( -.--% ) | - $ | 2026-07-31 |
| Företag | Position | Start |
|---|---|---|
| TYRA BIOSCIENCES, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2024-09-10 |
| Företag | Position | Slut |
|---|---|---|
| EFFECTOR THERAPEUTICS, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2024-06-21 |
| AMGEN INC. | Teknisk/Vetenskaplig/F&U Direktör | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 6 |
|---|---|
Amgen, Inc.
Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
UCLA Anderson School of Management
UCLA Anderson School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Duke University School of Medicine
Duke University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tyra Biosciences, Inc.
Tyra Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops cancer treatment drug therapies | Health Technology |
eFFECTOR Therapeutics, Inc.
eFFECTOR Therapeutics, Inc. BiotechnologyHealth Technology Operates as a oncology company which develops therapies for cancer | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån